News

This week's edition of the Mainstream Patient features stories about addictive behaviors stemming from skin care culture, the 21 best hyaluronic acid serums, and the struggles behind finding the right vitiligo treatment.

Although our tax code changes somewhat regularly, both real estate and cash value life insurance have shown superior tax treatment for decades.

From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.

ICYMI, this week we had stories about melanoma management with pembrolizumab, advances in rosacea therapy, new phase 2 data of VP-315 for BCC, and more.

Results of the phase 3 ECZTRA 6 trial found that the efficacy of the drug was maintained by more than 50% of patients at 52 weeks.

Ruxolitinib is the first and only approved treatment for repigmentation in the European Union.

Researchers said expression of the autoantigen was increased in patients.

Researchers pooled evidence supporting the way these 2 factors correlate.

A new study revealed that psoriasis patient adherence is influenced by certain characteristics of topical medications.

Approval has been pushed back to June 28, 2023.

Researchers said using the injections and mesotherapy in patients with acne more effectively treated their acne.

Researchers said emollients markedly reduced lesions and other atopic dermatitis-related factors.

Ritlecitinib was found to be effective and well-tolerated in patients aged 12 years and older.

Researchers also investigated how electric stimulation could be used to speed up wound healing in connection with diabetes, which affects wound healing due to impaired circulation and nerve damage.

Researchers identified several dermoscopic features associated with genes LINC00518, PRAME, and TERT.

Researchers said the drug is capable of restoring a healthy skin biome.

Block spoke to the founder of the Eczema Sample Store over Instagram Live to bring more awareness to the company’s mission.

The task force defined screening as a visual skin exam by a primary care clinician for this recommendation.

A key factor associated with delayed diagnosis for non-White patients is the lack of awareness that their symptoms are associated with a treatable medical condition, according to Oma Agbai, MD, and Lisa Nyanda-Manalo, MD.

In this week’s Pointers with Portela, the 208SkinDoc picks out affordable and travel-friendly skin care products at Target that everyone can benefit from.

The American Acne and Rosacea Society is spotlighting the issue as part of Rosacea Awareness Month.

Findings published in JDD suggest topical tranexamic acid can be used as first-line monotherapy.

The expected PDUFA date is December 16, 2023.

Brella received FDA clearance last week for improving excessive underarm sweating.

Researchers said responses may depend on prior immunotherapy.

The findings suggest a need to conduct cancer screening by a detailed history and comprehensive clinical examination in patients with PsA.

Researchers said occlusive materials used in gloves can lead to irritant contact dermatitis.

Click here to answer this week's poll.

The combination of punica granatum, citrus sinesis, f. cistanche, and centella asiatica revealed improved skin moisturization, radiance, and elasticity in a new study.

This week's edition of the Mainstream Patient features stories about the risks of phenol peels, the pros and cons of skin cycling, how to prevent stretch marks during pregnancy, and more.